GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 124 filers reported holding GENOMIC HEALTH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,056,000 | +51.7% | 15,575 | +30.1% | 0.00% | 0.0% |
| Q2 2019 | $696,000 | -38.1% | 11,972 | -25.4% | 0.00% | -50.0% |
| Q1 2019 | $1,125,000 | +22.3% | 16,058 | +12.5% | 0.00% | 0.0% |
| Q4 2018 | $920,000 | -13.4% | 14,276 | -5.6% | 0.00% | 0.0% |
| Q3 2018 | $1,062,000 | +40.8% | 15,120 | +1.1% | 0.00% | +100.0% |
| Q2 2018 | $754,000 | +67.9% | 14,962 | +4.4% | 0.00% | 0.0% |
| Q1 2018 | $449,000 | -5.5% | 14,338 | +3.3% | 0.00% | 0.0% |
| Q4 2017 | $475,000 | +12.8% | 13,877 | +5.8% | 0.00% | 0.0% |
| Q3 2017 | $421,000 | +1.7% | 13,113 | +3.0% | 0.00% | 0.0% |
| Q2 2017 | $414,000 | -17.7% | 12,734 | -46.4% | 0.00% | -50.0% |
| Q3 2015 | $503,000 | -20.3% | 23,760 | +4.6% | 0.00% | 0.0% |
| Q2 2015 | $631,000 | +24.5% | 22,710 | +36.8% | 0.00% | 0.0% |
| Q1 2015 | $507,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |